The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC).
 
Mary-Ellen Taplin
Honoraria - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen-Ortho; Pfizer; Research to Practice; UpToDate
Consulting or Advisory Role - AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; MDxHealth; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Christopher P. Evans
Stock and Other Ownership Interests - Exelixis
Honoraria - Janssen Oncology; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MDxHealth; Medivation; Sanofi
Speakers' Bureau - Astellas Pharma; Janssen Oncology; MDXHealth; Medivation; Sanofi
Research Funding - Astellas Pharma; Ferring; Medivation; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen Oncology; Sanofi
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Sanofi
 
Philip W. Kantoff
Stock and Other Ownership Interests - Context Therapeutics; Druggablity Technologies; Placon; Seer; Tarveda Therapeutics
Consulting or Advisory Role - Bavarian Nordic; BIND Biosciences; Context Therapeutics; Druggablity Technologies; GE Healthcare; Genentech/Roche; Janssen; Merck; Metamark Genetics; New England Research Institutes; OncoCellMDX; Progenity; Sanofi; Seer; Tarveda Therapeutics; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Chromosome Copy Number Gain as a Biomarker of Urothelial Carcinoma Lethality; Composition and Methods for Screening and Diagnosis of Prostate Cancer; Drug Combinations to Treat Cancer; Method for Predicting the Risk of Prostate Cancer Morbidity and Mortality; Methods and Kits for Determining Sensitivity to Cancer Treatment; Methods for Predicting Likelihood of Responding to Treatment; Predicting and Treating Prostate Cancer; Somatic ERCC2 Mutations Correlate with Cisplatin sensitivity in muscle-invasive Urothelial Carcinoma (Patent); Up-to-Date Royalties; Wolters Kluwer Royalties
Travel, Accommodations, Expenses - Druggablity Technologies; Sanofi
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Healthtronics
Consulting or Advisory Role - Healthtronics
Research Funding - metamark genetics
 
Neal D. Shore
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Research Funding - Sandoz-Novartis
 
Boris A. Hadaschik
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Lightpoint Medical
Research Funding - Astellas Pharma; Bristol-Myers Squibb; German Cancer Aid; German Research Foundation; Janssen; Profound Medical
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; Sanofi
 
Oliver Brendan Rooney
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Shaozhou Ken Tian
Employment - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patent for making cell blocks in cytology.
 
Lisa Wetherhold
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Weichun Xu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Shinta Cheng
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Adam S. Kibel
Honoraria - Blue Earth Diagnostics; InSightec; Janssen; Merck; Pfizer; profound